Πλοήγηση ανά Συγγραφέα "Kita, M."
-
Associations of obesity with modifiable risk factors for the development of cardiovascular disease in patients with rheumatoid arthritis
Stavropoulos-Kalinoglou, A.; Metsios, G. S.; Panoulas, V. F.; Douglas, K. M. J.; Nevill, A. M.; Jamurtas, A. Z.; Kita, M.; Koutedakis, Y.; Kitas, G. D. (2009)Objectives: To assess the association of body mass index (BMI) with modifiable cardiovascular disease (CVD) risk factors in patients with rheumatoid arthritis (RA). Methods: BMI, disease activity, selected CVD risk factors ... -
Cigarette smoking associates with body weight and muscle mass of patients with rheumatoid arthritis: a cross-sectional, observational study
Stavropoulos-Kalinoglou, A.; Metsios, G. S.; Panoulas, V. F.; Douglas, K. M. J.; Nevill, A. M.; Jamurtas, A. Z.; Kita, M.; Koutedakis, Y.; Kitas, G. D. (2008)Introduction Rheumatoid arthritis (RA) is associated with altered metabolism leading to muscle wasting. In the general population, cigarette smoking is known to affect body composition by reducing fat and inhibiting muscle ... -
Effect of Exogenous Intermittent Recombinant Human PTH 1-34 Administration and Chronic Endogenous Parathyroid Hormone Excess on Glucose Homeostasis and Insulin Sensitivity
Anastasilakis, A. D.; Efstathiadou, Z.; Plevraki, E.; Koukoulis, G. N.; Slavakis, A.; Kita, M.; Avramidis, A. (2008)We aimed to evaluate the effects of exogenous intermittent teriparatide (rhPTH 1-34) administration versus the chronic exposure to excess endogenous parathyroid hormone (PTH), as in pHPT, on glucose homeostasis. Two patient ... -
Endogenous intact PTH is suppressed during teriparatide (rhPTH 1-34) administration in postmenopausal women with established osteoporosis
Anastasilakis, A. D.; Polyzos, S. A.; Goulis, D. G.; Slavakis, A.; Efstathiadou, Z.; Kita, M.; Koukoulis, G.; Avramidis, A. (2008)Introduction: Teriparatide (recombinant human PTH 1-34/TPTD) is an osteoanabolic agent available for osteoporosis treatment. The aim of this prospective trial was to evaluate the acute and chronic effects of TPTD in ... -
Head-to-head comparison of risedronate vs. teriparatide on bone turnover markers in women with postmenopausal osteoporosis: a randomised trial
Anastasilakis, A. D.; Goulis, D. G.; Polyzos, S. A.; Gerou, S.; Koukoulis, G. N.; Efstathiadou, Z.; Kita, M.; Avramidis, A. (2008)Aims: We aimed to compare the effect of risedronate (RIS) and teriparatide (TPTD) (recombinant human parathyroid hormone 1-34) on bone turnover markers in women with postmenopausal osteoporosis. Methods: Forty-four Caucasian ... -
Oxidative Stress and Reduced Antioxidative Status, along with Endothelial Dysfunction in Acromegaly
Anagnostis, P.; Efstathiadou, Z. A.; Gougoura, S.; Polyzos, S. A.; Karathanasi, E.; Dritsa, P.; Kita, M.; Koukoulis, G. N. (2013)Acromegaly is characterized by high cardiovascular morbidity and mortality. Oxidative stress and endothelial dysfunction are underlying mechanisms of atherosclerosis. The aim of this study was to evaluate the blood redox ... -
Serum osteoprotegerin and RANKL are not specifically altered in women with postmenopausal osteoporosis treated with teriparatide or risedronate: A randomized, controlled trial
Anastasilakis, A. D.; Goulis, D. G.; Polyzos, S. A.; Gerou, S.; Koukoulis, G.; Kita, M.; Avramidis, A. (2008)Risedronate and teriparatide have opposite actions on the osteoblast-osteoclast dipole and are expected to influence the RANK/RANKL/ osteoprotegerin (OPG) system. We aimed to evaluate changes in serum OPG and RANKL after ...